SCHEMBL9920637

SCHEMBL9920637

Cc1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5cc(-c6cc(-c7ccccc7)cc(-c7ccccc7)c6)ccc54)cc3)c3ccc4cc(C(C)(C)C)cc5ccc2c3c54)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32
TSPO P30536 1/20 0.32
PTGER4 P35408 1/20 0.31
CYP2C9 P11712 1/20 0.31
HTT P42858 1/20 0.31
NPY5R Q15761 1/20 0.31
PPARG P37231 1/20 0.30
PTGES O14684 1/20 0.30
HPRT1 P00492 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920850 0.98 ALDH1A1 (0.35) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920855 0.96 ALDH1A1 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9921108 0.95 ALDH1A1 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920765 0.94 ALDH1A1 (0.37) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920659 0.94 ALDH1A1 (0.37) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL21234908 0.94 KDM4E (0.36) ALDH1A1MAPTNPSR1MAPK1KDM4E
SCHEMBL9921090 0.93 ALDH1A1 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920782 0.93 ALDH1A1 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920778 0.92 ALDH1A1 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL9920853 0.91 PIK3CD (0.33) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
EP-1942171-B1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES (JP) 2018-04-18 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 AKR1C4 3141/4885AKR1C3 2786/4885AKR1C2 3521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.